Dushmanthi A. Jayasinghe

发表

Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study

D. Goodenowe, P. Wood, Hong Ma, 2010, Lipids in Health and Disease.

Metabolic system alterations in pancreatic cancer patient serum: potential for early detection

D. Goodenowe, Y. Yamazaki, H. Eguchi, 2013, BMC Cancer.

Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection

Kevin F Krenitsky, D. Goodenowe, Y. Yamazaki, 2010, BMC medicine.

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia Published, JLR Papers in Press, August 2, 2007.

Kevin F Krenitsky, L. L. Cook, D. Sparks, 2007, Journal of Lipid Research.

Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.

D. Goodenowe, S. Ritchie, Wei Jin, 2015, World journal of gastroenterology.

Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice

D. Goodenowe, T. Di Paolo, Li Wang, 2016, PloS one.

Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata

N. Braverman, E. Di Pietro, S. Ritchie, 2019, Disease Models & Mechanisms.

Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity

D. Goodenowe, Hong Ma, S. Ritchie, 2011, Journal of experimental & clinical cancer research : CR.

Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor

T. Di Paolo, D. Soulet, J. Lamontagne-Proulx, 2019, Brain Research.

Plasmalogen precursor mitigates striatal dopamine loss in MPTP mice

M. Morissette, M. Bourque, T. Paolo, 2017, Brain Research.

RELATION OF PLASMALOGEN BIOSYNTHESIS TO COGNITION AND AD IN OLDER PERSONS

D. Bennett, D. Goodenowe, R. Shah, 2014, Alzheimer's & Dementia.